Molecular biologic studies in the clinical evaluation of non-Hodgkin's lymphoma.
Recent advances in DNA technology have revealed new information about the biology of the non-Hodgkin's lymphomas that is both provocative and exciting. Because these technologies are just beginning to be applied to the clinical evaluation of the non-Hodgkin's lymphomas, the results of clinical studies must be regarded as preliminary. At this time we can only speculate on how they might lead to improved clinical management or provide the basis for new therapies.
Department of Medicine, Stanford University, California.
R
R
Hardy
S J
SJ
Horning
D015321:Gene Rearrangement; D005821:Genetic Techniques; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000235:genetics*; D009857:Oncogenes / Q000235:genetics; D011947:Receptors, Antigen, B-Cell / Q000235:genetics; D011948:Receptors, Antigen, T-Cell / Q000235:genetics; D014178:Translocation, Genetic
D011947:Receptors, Antigen, B-Cell; D011948:Receptors, Antigen, T-Cell